Conquering epilepsies & brain disorders with courageous science
boldvision
Science-driven and patient-focused, our mission is to develop medicines that transform the lives of patients with epilepsies and seizure-related disorders.
boldscience
Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for epilepsies and seizure-related disorders.
boldcommitment
At Ovid, we seek to understand what matters most to individuals with rare diseases and their families. We are committed to address the challenges they face every day.
press releases
- Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 Trial
- Ovid Therapeutics to Present Data on Its Epilepsy Programs at American Epilepsy Society Annual Meeting (2022)
- Ovid Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights
- Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference
boldpeople
Each team member understands the difference between a drug and a medicine—one is a product, the other changes lives—and that's what brings us together as Ovidians.